This is an updated report to the one that was release late last...

This is an updated report to the one that was release late last week. (See the Biota website - www.biota.com.au)

There are a number of other reports on the web site but they haven't yet been updated.

The valuation hasn't actually changed. The author has changed the recommendation from buy to hold.

The step change in share price has really been just to get to thier target valuation in less than 24hrs.

The SP appreciation probably isn't that rediculous after all.

The SP recommendation takes no account for any future swine flu resistance to Tamiflu (which would make Relenza the only usable antiviral for H1N1).